Related Experiment Videos
Crosstalk between inflammation and thrombosis
1Department of Pathology, University of Oklahoma Health Sciences Center, Howard Hughes Medical Institute, 825 NE 13th Street, Oklahoma City, OK 73104, USA. charles-esmon@omrf.ouhsc.edu
Maturitas
|April 6, 2004
Summary
Inflammation promotes blood clots by disrupting natural anticoagulants like the protein C pathway. Restoring this pathway may reduce inflammation and prevent microvascular dysfunction, especially in sepsis.
Area of Science:
- Biochemistry
- Hematology
- Immunology
Background:
- Inflammation promotes thrombosis through mechanisms like increased tissue factor and PAI-1.
- Natural anticoagulant pathways, particularly the protein C pathway, are downregulated during inflammation.
- Impaired protein C pathway function exacerbates inflammatory responses and endothelial injury.
Purpose of the Study:
- To examine the impact of inflammation on the protein C anticoagulant pathway.
- To elucidate the role of the protein C pathway in modulating inflammatory responses.
- To understand how protein C pathway dysfunction contributes to microvascular complications in sepsis.
Main Methods:
- Investigated the regulation of thrombomodulin (TM) and endothelial cell protein C receptor (EPCR) by inflammatory mediators.
- Assessed the effects of inhibiting the protein C pathway on inflammatory markers and endothelial cell function.
- Evaluated the therapeutic potential of activated protein C (APC) in preclinical models of inflammation and sepsis.
Main Results:
- Inflammatory mediators downregulate EPCR and TM, impairing protein C activation.
- EPCR shedding and nuclear translocation influence gene expression and leukocyte interactions.
- Protein C pathway inhibition amplifies inflammatory responses, while APC infusion mitigates these effects.
- APC demonstrated anti-inflammatory properties, inhibiting cytokine production and leukocyte adhesion.
Conclusions:
- The protein C pathway is a critical regulator of inflammation and coagulation.
- Dysfunction of the protein C pathway during inflammation contributes to thrombosis and endothelial injury.
- Targeting the protein C pathway, particularly with APC, holds therapeutic potential for inflammatory conditions and sepsis-associated microvascular dysfunction.